Newsfeeds Archive - Page 36 of 696

3 minute read

Paranovus Entertainment Technology Ltd Signs Letter Of Intent To Acquire BlueLine Studios, Pivoting To AI-Entertainment For ~$3.2M In Cash And Unregistered Class A Ordinary Shares

September 6, 8:36 AM

Expansion into AI-powered online entertainment industry reflects strategic evolution of the business model NANPING, China, Sept. 6, 2023 /PRNewswire/ -- Paranovus Entertainment Technology Ltd.

PAVS

2 minute read

Xponential Fitness Issues Three-Year Operating Targets And Provides Strategic Updates Ahead Of Analyst And Investor Day; 2026 Operating Targets Include New Studio Openings Of 500, System-Wide Sales Of $2.330B, Revenue Of $405M And Adjusted EBITDA Of $1…

By Happy Mohamed

September 6, 8:34 AM

2026 operating targets include new studio openings of 500, system-wide sales of $2.330 billion, revenue of $405.0 million and Adjusted EBITDA of $190.0 million Announces new partnership with

XPOF

3 minute read

News

Sonos Introduces Move 2, Revamped Inside And Out To Deliver Heart-Pumping Stereo Sound

By Happy Mohamed

September 6, 8:23 AM

https://www.sonos.com/en-ie/newsroom/sonos-introduces-move-2 Sonos (NASDAQ:SONO) today debuted Move 2, the next generation of its best-selling Move speaker, that delivers spacious stereo sound, up to 24

SONO

3 minute read

Charles River And PathoQuest Announce Publication Of A Head-To-Head Study Validating Proprietary Next Generation Sequencing Viral Safety Assay As A Reliable In Vitro Alternative To Animal Testing Methods

By Happy Mohamed

September 6, 8:20 AM

NGS assay demonstrated a broader detection range than standard in vivo tests with comparable or higher analytical sensitivity Charles River Laboratories International, Inc. (NYSE:CRL) and PathoQuest SAS, a leader in the

CRL

2 minute read

VBI Vaccines Partner Brii Biosciences Announces Topline Interim Results Of Phase 2 Study Evaluating BRII-179 In Combination With PEG-IFNα For The Treatment Of Chronic Hepatitis B

By Happy Mohamed

September 6, 8:19 AM

BRII-179 (VBI-2601) as an add-on therapy to standard of care PEG-IFNα increases HBsAg loss rate at the end of treatment and 12 weeks follow up Significantly increased seroconversion rate is strongly associated

VBIV

2 minute read

Gracell Biotechnologies To Present Updated Clinical Data On BCMA/CD19 Dual-Targeting FasTCAR-T GC012F In Newly Diagnosed Multiple Myeloma At The 2023 International Myeloma Society Annual Meeting

By Happy Mohamed

September 6, 8:18 AM

Gracell Biotechnologies Inc. ((", Gracell", or the ", Company", , NASDAQ:GRCL), a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell

GRCL

3 minute read

ALX Oncology Realigns Executive Leadership Team, Jason Lettmann Appointed As Chief Executive Officer

By Happy Mohamed

September 6, 8:17 AM

ALX Oncology Holdings Inc., ("ALX Oncology" or "the Company") (NASDAQ:ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today announced that Jason

ALXO

1 minute read

News

Stronghold Digital Mining Announces August 2023 Bitcoin Mining Update

By Happy Mohamed

September 6, 8:15 AM

Stronghold Digital Mining, Inc. (NASDAQ:SDIG) ("Stronghold", or the "Company") today provided the following updates regarding its operations and financial performance: August Bitcoin

SDIG

3 minute read

News

City of Boston Selects Genasys Protect To Power Its Preparedness And Emergency Communication

By Happy Mohamed

September 6, 8:14 AM

Genasys (NASDAQ:GNSS), the global leader in protective communications solutions, today announced the City of Boston replaced its mass notification system and has deployed Genasys Protect™, the first

GNSS

2 minute read

Bionano Announces Peer-Reviewed Publication On The Utility Of Combining OGM And WES For Evaluation Of Pediatric Leukemia

By Happy Mohamed

September 6, 8:14 AM

Bionano Genomics, Inc. (NASDAQ:BNGO) today announced a peer-reviewed publication from researchers at the German Cancer Consortium (DKTK) showing the utility of optical genome mapping (OGM) and whole-exome

BNGO